Benfluorex and valvular heart disease: a French pharmacovigilance survey

被引：0
|
作者：
Vial, T. [1 ]
Bernard, N. [1 ]
Micaleff, J. [2 ]
Gras-Champel, V. [3 ]
Gautier, S. [4 ]
Petitpain, N. [5 ]
Daveluy, A. [6 ]
Sgro, C. [7 ]
机构：
[1] Hosp Civils Lyon, Ctr Reg Pharmacovigilance, 162A,Ave Lacassagne, Lyon, France
[2] Assistance Publ Hop Marseille, Ctr Reg Pharmacovigilance, 270 Blvd St Marguerite, Marseille, France
[3] CHU Amiens Sud, Ctr Reg Pharmacovigilance, Amiens, France
[4] CHRU, Ctr Reg Pharmacovigilance, 1 Pl Verdun, Lille, France
[5] Hop Cent, Ctr Reg Pharmacovigilance, 29 Ave Marechal de Lattre Tassigny, Nancy, France
[6] Hop Pellegrin, Ctr Reg Pharmacovigilance, F-33076 Bordeaux, France
[7] CHU Pole Vigilances, Ctr Reg Pharmacovigilance, 14 Rue Paul Gaffarel,BP 77908, Dijon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2-016
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Benfluorex and valvular heart disease
    Tribouilloy, Christophe
    Jeu, Antoine
    Marechaux, Sylvestre
    Jobic, Yannick
    Rusinaru, Dan
    Andrejak, Michel
    PRESSE MEDICALE, 2011, 40 (11): : 1008 - 1016
  • [2] Benfluorex and Valvular Heart Disease
    Kirkorian, Gilbert
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (10)
  • [3] Valvular heart disease associated with benfluorex
    Ribera, JR
    Muñoz, RC
    Ferrando, NA
    Sahún, NB
    Cels, AC
    Capmany, RP
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (02): : 215 - 216
  • [4] Valvular heart disease associated with benfluorex
    Gueffet, Jean-Pierre
    Piriou, Nicolas
    Trochu, Jean-noel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (05) : 342 - 343
  • [5] Letter on the article: "Benfluorex and valvular heart disease"
    Jobic, Yannick
    Etienne, Yves
    Tribouilloy, Christophe
    Bruneval, Patrick
    Frachon, Irene
    PRESSE MEDICALE, 2012, 41 (03): : 326 - 327
  • [6] Valvular heart disease in a patient taking benfluorex
    Noize, P.
    Sauer, M.
    Bruneval, P.
    Moreau, M.
    Pathak, A.
    Bagheri, H.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (06) : 577 - 578
  • [7] Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry
    Le Ven, Florent
    Tribouilloy, Christophe
    Habib, Gilbert
    Gueffet, Jean-Pierre
    Marechaux, Sylvestre
    Eicher, Jean-Christophe
    Blanchard-Lemoine, Benedicte
    Rousseau, Juliette
    Henon, Pierre
    Jobic, Yannick
    Etienne, Yves
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (04): : 265 - 271
  • [8] Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease
    Boudes, Audrey
    Lavoute, Cecile
    Avierinos, Jean-Francois
    Le Dolley, Yvan
    Villacampa, Chloe
    Salem, Adrien
    Loundou, Anderson Dieudonne
    Michel, Nicolas
    Renard, Sebastien
    Habib, Gilbert
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (09): : 688 - 695
  • [9] Benfluorex and unexplained valvular heart disease: a case- control study
    Frachon, I.
    Etienne, Y.
    Jobic, Y.
    Le gal, G.
    Lacut, K.
    Humbert, M.
    Leroyer, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 6 - 6
  • [10] Benfluorex: the last chapter of drug-induced valvular heart disease?
    Droogmans, Steven
    Cosyns, Bernard
    Van Camp, Guy
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (04): : 263 - 264
12345